Potential therapy target for cardiac arrhythmias found in SK2 channels

byUniversity of ArizonaCredit: Unsplash/CC0 Public DomainA new study by researchers at the University of Arizona College of Medicine–Phoenix and the University of California Davis Health identif

Cardiology & Vascular surgery October 21,2024 0

Potential therapy target for cardiac arrhythmias found in SK2 channels

byUniversity of ArizonaCredit: Unsplash/CC0 Public DomainA new study by researchers at the University of Arizona College of Medicine–Phoenix and the University of California Davis Health identif

Cardiology & Vascular surgery October 21,2024 0

Long COVID: Study finds lithium aspartate at low doses is ineffective, but higher doses may be promising

byUniversity at BuffaloCredit: Andrea Piacquadio from PexelsA small University at Buffalo clinical trial has found that at low doses, lithium aspartate is ineffective in treating the fatigue and

Epidemiology & Public Health October 21,2024 0

Long COVID: Study finds lithium aspartate at low doses is ineffective, but higher doses may be promising

byUniversity at BuffaloCredit: Andrea Piacquadio from PexelsA small University at Buffalo clinical trial has found that at low doses, lithium aspartate is ineffective in treating the fatigue and

Epidemiology & Public Health October 21,2024 0

Researchers identify new therapeutic approach to preventing cancer from spreading to the brain

byMcMaster UniversityCredit: CC0 Public DomainIn a studypublishedin the journalCell Reports Medicine, researchers Sheila Singh and Jakob Magolan discovered a critical vulnerabi

Oncology October 21,2024 0

Researchers identify new therapeutic approach to preventing cancer from spreading to the brain

byMcMaster UniversityCredit: CC0 Public DomainIn a studypublishedin the journalCell Reports Medicine, researchers Sheila Singh and Jakob Magolan discovered a critical vulnerabi

Oncology October 21,2024 0

Synthetic peptide acts as molecular shield to prevent SARS-CoV-2 from infecting cells

by Julia Moióli,FAPESPThe figure shows the interaction between the synthetic ACE2 peptide (yellow) and the SARS-CoV-2 spike protein. The spikes of the original viral strain from Wuhan and the om

Epidemiology & Public Health October 21,2024 0

Synthetic peptide acts as molecular shield to prevent SARS-CoV-2 from infecting cells

by Julia Moióli,FAPESPThe figure shows the interaction between the synthetic ACE2 peptide (yellow) and the SARS-CoV-2 spike protein. The spikes of the original viral strain from Wuhan and the om

Epidemiology & Public Health October 21,2024 0

Why isn't the pharmaceutical industry using this alternative to horseshoe crab blood?

byUniversity of MichiganCredit: CC0 Public DomainSince the 1960s when the bright-blue blood of horseshoe crabs was first discovered as a way to detect bacteria in vaccines and other injectables,

Pharma Science October 21,2024 0

Why isn't the pharmaceutical industry using this alternative to horseshoe crab blood?

byUniversity of MichiganCredit: CC0 Public DomainSince the 1960s when the bright-blue blood of horseshoe crabs was first discovered as a way to detect bacteria in vaccines and other injectables,

Pharma Science October 21,2024 0

Precision breast cancer trial shows improved treatment by tumor subtype

byUniversity of California, San FranciscoEfficacy of Dato-DXd + durvalumab treatment. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-03267-1Despite recent advances in the trea

Oncology October 21,2024 0

Precision breast cancer trial shows improved treatment by tumor subtype

byUniversity of California, San FranciscoEfficacy of Dato-DXd + durvalumab treatment. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-03267-1Despite recent advances in the trea

Oncology October 21,2024 0

Clinical trial finds new drug significantly extends lives of breast cancer patients

byLudwig Maximilian University of MunichKaplan–Meier analysis of key efficacy endpoints in patients with baseline BMs. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-03261-7Pa

Oncology October 21,2024 0

Clinical trial finds new drug significantly extends lives of breast cancer patients

byLudwig Maximilian University of MunichKaplan–Meier analysis of key efficacy endpoints in patients with baseline BMs. Credit:Nature Medicine(2024). DOI: 10.1038/s41591-024-03261-7Pa

Oncology October 21,2024 0

Experts release the latest guide for systematic reviews of preclinical research

byRadboud UniversityCredit: Unsplash/CC0 Public DomainA new publication inNature Reviews Methods Primersprovides essential guidance for conducting rigorous systematic reviews on stud

Medical research October 21,2024 0

Experts release the latest guide for systematic reviews of preclinical research

byRadboud UniversityCredit: Unsplash/CC0 Public DomainA new publication inNature Reviews Methods Primersprovides essential guidance for conducting rigorous systematic reviews on stud

Medical research October 21,2024 0

Reducing sitting by about 40 minutes daily may prevent back pain, research suggests

byUniversity of TurkuChange in back pain intensity on a scale from 0 to 10. The blue bars represent individuals in the intervention group that reduced sitting and the red bars represent the cont

Orthopedics & Sports medicine October 21,2024 0

Reducing sitting by about 40 minutes daily may prevent back pain, research suggests

byUniversity of TurkuChange in back pain intensity on a scale from 0 to 10. The blue bars represent individuals in the intervention group that reduced sitting and the red bars represent the cont

Orthopedics & Sports medicine October 21,2024 0

Event-free survival extended with long-term finerenone in heart failure

by Elana GotkineLong-term treatment with finerenone is estimated to extend event-free survival among people with heart failure with mildly reduced or preserved ejection fraction, according to a brief

Cardiology & Vascular surgery October 21,2024 0

Event-free survival extended with long-term finerenone in heart failure

by Elana GotkineLong-term treatment with finerenone is estimated to extend event-free survival among people with heart failure with mildly reduced or preserved ejection fraction, according to a brief

Cardiology & Vascular surgery October 21,2024 0